Clinical Trial Update: Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin hydrochloride in patients with prostate cancer undergoing surgery has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-15